Going all in, 80k @ $28.44/share.
They hired former CCO of Eli Lilly about a month ago to potentially prepare for commercialization or buyout, assuming for their weight loss drug VK2735 (entering phase 3). If that isn’t a signal of intent idk what is.
See you all @ Wendy’s